146 related articles for article (PubMed ID: 3793961)
1. Continuous arteriovenous hemofiltration of aminoglycoside antibiotics in critically ill patients.
Zarowitz BJ; Anandan JV; Dumler F; Jayashankar J; Levin N
J Clin Pharmacol; 1986; 26(8):686-9. PubMed ID: 3793961
[TBL] [Abstract][Full Text] [Related]
2. Variable pharmacokinetics of extended interval tobramycin or gentamicin among critically ill patients undergoing continuous venovenous hemofiltration.
Chuk AC; Saeed F; Kousar N; Burrill S; Barns B; Rickrode G; Fu J; Katrych O; Saunders-Hao P; Block C; Lahey T
Clin Nephrol; 2015 Oct; 84(4):214-21. PubMed ID: 26308080
[TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetics of aminoglycosides in critically ill trauma patients on once-daily regimens.
Barletta JF; Johnson SB; Nix DE; Nix LC; Erstad BL
J Trauma; 2000 Nov; 49(5):869-72. PubMed ID: 11086778
[TBL] [Abstract][Full Text] [Related]
4. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA
Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533
[TBL] [Abstract][Full Text] [Related]
5. Aminoglycoside Pharmacokinetics in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy.
Krueger CK; Bruno JJ; Tverdek FP; Hernandez M; Abudayyeh A
Ann Pharmacother; 2023 Jun; 57(6):629-636. PubMed ID: 36062536
[TBL] [Abstract][Full Text] [Related]
6. Suboptimal aminoglycoside dosing in critically ill patients.
Rea RS; Capitano B; Bies R; Bigos KL; Smith R; Lee H
Ther Drug Monit; 2008 Dec; 30(6):674-81. PubMed ID: 19057371
[TBL] [Abstract][Full Text] [Related]
7. Aminoglycoside levels in critically ill surgical patients: the implications of physiologic criteria of sepsis.
Cornwell EE; Belzberg H; Berne TV; Kern JW; Henriques G; Asensio JA; Demetriades D
South Med J; 1997 Jan; 90(1):33-6. PubMed ID: 9003820
[TBL] [Abstract][Full Text] [Related]
8. Initial aminoglycoside levels in the critically ill.
Summer WR; Michael JR; Lipsky JJ
Crit Care Med; 1983 Dec; 11(12):948-50. PubMed ID: 6641254
[TBL] [Abstract][Full Text] [Related]
9. Determination of serum concentrations of some aminoglycoside antibiotics by use of the fluorescent immunoassay method.
Dzierzanowska D; Nowik-Jurek M; Podleśny J
Arch Immunol Ther Exp (Warsz); 1983; 31(3):389-94. PubMed ID: 6651487
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacologic studies or aminoglycoside antibiotics (amikacin, gentamicin, sisomicin, tobramycin)].
Lode H; Grunert K; Kemmerich B; Koeppe P
Adv Clin Pharmacol; 1978; 15():35-44. PubMed ID: 676877
[TBL] [Abstract][Full Text] [Related]
11. Impact of aminoglycoside serum assays on clinical decisions and renal toxicity.
Arroyo JC; Milligan WL; Davis J; Mitchell D
South Med J; 1986 Mar; 79(3):272-6. PubMed ID: 3513326
[TBL] [Abstract][Full Text] [Related]
12. [Serum level-adjusted dosage of once-daily aminoglycoside therapy in critical illness: results of a prospective study].
Reimann IR; Meier-Hellmann A; Pfeifer R; Traut T; Schilling A; Stein G; Reinhart K; Hoffmann A
Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 May; 34(5):288-95. PubMed ID: 10372218
[TBL] [Abstract][Full Text] [Related]
13. Predictability of serum concentrations of aminoglycosides after haemodialysis.
Dijkmans BA; Mattie H
Eur J Clin Pharmacol; 1987; 33(2):179-83. PubMed ID: 3691608
[TBL] [Abstract][Full Text] [Related]
14. Aminoglycoside Dosing and Volume of Distribution in Critically Ill Surgery Patients.
Grucz TM; Kruer RM; Bernice F; Lipsett PA; Dorman T; Sugrue D; Jarrell AS
Surg Infect (Larchmt); 2020 Dec; 21(10):859-864. PubMed ID: 32302517
[No Abstract] [Full Text] [Related]
15. Interactions between aminoglycoside antibiotics and carbenicillin or ticarillin.
Holt HA; Broughall JM; McCarthy M; Reeves DS
Infection; 1976; 4(2):107-9. PubMed ID: 7534
[TBL] [Abstract][Full Text] [Related]
16. The aminoglycoside panel: a new approach to monitoring aminoglycoside therapy.
Gorsky JE; Latts JR
Ther Drug Monit; 1983 Jun; 5(2):169-72. PubMed ID: 6879640
[TBL] [Abstract][Full Text] [Related]
17. Effect of pharmacokinetic sampling methods on aminoglycoside dosing in critically ill surgery patients.
Mann HJ; Wittbrodt ET; Baghaie AA; Cerra FB
Pharmacotherapy; 1998; 18(2):371-8. PubMed ID: 9545157
[TBL] [Abstract][Full Text] [Related]
18. Vancomycin and tobramycin clearance in an infant during continuous hemofiltration.
Armstrong DK; Hidalgo HA; Eldadah M
Ann Pharmacother; 1993 Feb; 27(2):224-7. PubMed ID: 8439703
[TBL] [Abstract][Full Text] [Related]
19. Assessment of aminoglycoside dosing and estimated glomerular filtration rate in determining gentamicin and tobramycin area under the curve and clearance.
Lim AK; Mathanasenarajah G; Larmour I
Intern Med J; 2015 Mar; 45(3):319-29. PubMed ID: 25581282
[TBL] [Abstract][Full Text] [Related]
20. Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.
Mars RL; Moles K; Pope K; Hargrove P
Adv Perit Dial; 2000; 16():280-4. PubMed ID: 11045311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
